Form D · Biotechnology

Novilytic, LLC

West Lafayette, IN · CIK 0001850261

Offering snapshot reported Dec 15, 2025 · SEC filing

Reported sold
$531K
Offering amount: $1M
Investors reported
8
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Dec 1, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 15, 2025Initial$530,800No comparison8SEC filing
Apr 13, 2021Initial$950,000No comparison7SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-566764

Source: Form D, filed Dec 15, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jiri Adamec Director
Paul C Dreier Director, Executive, Promoter
Jonathan Edwardsen Director
Johnston Erwin Director
Fred E Regnier Director, Executive
Alan Symons Director
Timothy E Woenker Director
Edward W Woenker Director
Rich Wynne Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1281 Win Hentschel Blvd
West Lafayette, IN, 47906